1 Min Read
May 28 (Reuters) - Onxeo SA :
* Announces preclinical & clinical data from three studies supporting the potential for Belinostat in multiple orphan oncology indications
Source text: bit.ly/1FFncYJ Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.